VBIO (Valion Bio, Inc. Common Stock) Stock Analysis - SEC Filings

Valion Bio, Inc. Common Stock (VBIO) is a publicly traded the market company. As of May 21, 2026, VBIO trades at $0.85 with a market cap of $2.70M and a P/E ratio of 0.00. VBIO moved +0.00% today. Year to date, VBIO is +0.00%; over the trailing twelve months it is flat. Its 52-week range spans $0.80 to $1.21. Rallies surfaces VBIO's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

Where can I find VBIO SEC filings?

Rallies organizes VBIO SEC filing research, company disclosures, 10-K reports, 10-Q reports, and filing-driven context alongside market data, news, fundamentals, and AI research.

VBIO Key Metrics

Key financial metrics for VBIO
MetricValue
Price$0.85
Market Cap$2.70M
P/E Ratio0.00
EPS$0.00
Dividend Yield0.00%
52-Week High$1.21
52-Week Low$0.80
Volume1.88K
Avg Volume0
Revenue (TTM)$0
Net Income$0
Gross Margin0.00%

Latest VBIO News

Recent VBIO Insider Trades

  • LoConti Joseph E. bought 1.00K (~$200) on Jul 29, 2021.
  • LoConti Joseph E. bought 13.00K (~$2.60K) on Jul 20, 2021.
  • LoConti Joseph E. bought 40.00K (~$6.40K) on Jul 19, 2021.

VBIO Analyst Consensus

VBIO analyst coverage data. Average price target: $0.00.

Common questions about VBIO

Where can I find VBIO SEC filings?
Rallies organizes VBIO SEC filing research, company disclosures, 10-K reports, 10-Q reports, and filing-driven context alongside market data, news, fundamentals, and AI research.
Does Rallies show VBIO 10-K and 10-Q filings?
Rallies organizes VBIO SEC filing research, including 10-K reports, 10-Q reports, company disclosures, and filing-driven context when available.
Is VBIO research on Rallies investment advice?
No. Rallies provides research, data, and educational context for VBIO. It does not provide personalized investment advice.
VBIO

VBIO